FindTrial
Sign In

Study on the registration of rheumatic valvular disease in Fuwai

Based on a cohort study of patients with rheumatic heart disease in a single center in Fuwai Hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047353
Enrollment
Unknown
Registered
2021-06-12
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic heart disease

Interventions

Case series:Null

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with rheumatic heart disease/rheumatic valvular disease from January 1, 2010 to December 31, 2019 (diagnosis refers to the 2012 WHF Rheumatic Heart Disease Management Guidelines).

Exclusion criteria

Exclusion criteria: 1. The patient had undergone heart valve surgery before admission; 2. The patient's data is missing.

Design outcomes

Primary

MeasureTime frame
all-cause death;—

Secondary

MeasureTime frame
ischemic stroke or transient cerebral ischemia;pulmonary embolism;peripheral arterial embolism;major bleeding;myocardial infarction;heart failure;—

Countries

China

Contacts

Public ContactLi Zi'ang

Fuwai Hospital, Chinese Academy of Medical Sciences

liziang@fuwaihospital.org+86 16619775680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026